Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
爲什麼Sangamo Therapeutics的股票在盤前交易中上漲約20%;這裏有20只股票在盤前交易中波動。
Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) rose sharply in today's pre-market trading.
Sangamo Therapeutics, Inc.(納斯達克:SGMO)的股票在今天的美股盤前交易中大幅上漲。
Astellas and Sangamo Therapeutics disclosed Capsid license agreement to deliver genomic medicines for neurological diseases.
Astellas和Sangamo Therapeutics披露了一個載體許可協議,以提供用於神經疾病的基因治療。
Sangamo Therapeutics shares jumped 19.5% to $2.81 in the pre-market trading session.
Sangamo Therapeutics的股票在美股盤前交易中上漲了19.5%,達到$2.81。
Here are some other stocks moving in pre-market trading.
以下是一些在美股盤前交易中表現活躍的其他股票。
Gainers
漲幅
- CURRENC Group Inc. (NASDAQ:CURR) gained 219.5% to $6.39 in pre-market trading after jumping 54% on Wednesday.
- XChange TEC.INC (NASDAQ:XHG) climbed 170% to $2.13 in pre-market trading after declining over 50% on Wednesday.
- AppTech Payments Corp. (NASDAQ:APCX) gained 170% to $1.03 in pre-market trading.
- Silexion Therapeutics Corp (NASDAQ:SLXN) gained 68% to $3.55 in pre-market trading after dropping 26% on Wednesday.
- Mesoblast Limited (NASDAQ:MESO) rose 44.5% to $17.70 in pre-market trading. Mesoblast's RYONCIL became the first FDA-approved mesenchymal stromal cell therapy in the U.S.
- Elevai Labs Inc. (NASDAQ:ELAB) gained 38.6% to $2.98 in pre-market trading after gaining 9% on Wednesday.
- Dallasnews Corp (NASDAQ:DALN) gained 38% to $6.72 in pre-market trading after falling 5% on Wednesday.
- KULR Technology Group, Inc. (NASDAQ:KULR) rose 28% to $2.68 in pre-market trading after jumping 44% on Wednesday.
- XCHG Limited (NASDAQ:XCH) gained 24.2% to $2.67 in pre-market trading after dipping more than 90% on Wednesday.
- CURRENC Group Inc.(納斯達克:CURR)在美股盤前交易中上漲了219.5%,達到$6.39,週三上漲了54%。
- XChange TEC.INC(納斯達克:XHG)在美股盤前交易中上漲了170%,達到$2.13,週三下跌超過50%。
- AppTech Payments CORP.(納斯達克:APCX)在美股盤前交易中上漲了170%,達到$1.03。
- Silexion Therapeutics CORP(納斯達克:SLXN)在美股盤前交易中上漲68%,達$3.55,此前週三下跌了26%。
- Mesoblast Limited(納斯達克:MESO)在美股盤前交易中上漲44.5%,達$17.70。Mesoblast的RYONCIL成爲美國首個獲得FDA批准的間充質幹細胞療法。
- Elevai Labs Inc.(納斯達克:ELAB)在美股盤前交易中上漲38.6%,達$2.98,此前週三上漲了9%。
- Dallasnews CORP(納斯達克:DALN)在美股盤前交易中上漲38%,達$6.72,此前週三下跌了5%。
- KULR Technology Group, Inc.(納斯達克:KULR)在美股盤前交易中上漲28%,達$2.68,此前週三跳漲了44%。
- XCHG Limited(納斯達克:XCH)在美股盤前交易中上漲24.2%,達$2.67,此前週三下跌超過90%。
Losers
失敗者
- Snow Lake Resources Ltd. (NASDAQ:LITM) shares tumbled 40.5% to $0.4847 in pre-market trading after jumping 348% on Wednesday.
- Aethlon Medical, Inc. (NASDAQ:AEMD) declined 36.4% to $0.42 in pre-market trading after jumping more than 80% on Wednesday.
- Abacus Life, Inc. (NASDAQ:ABL) shares fell 20.5% to $6.00 in pre-market trading.
- Lamb Weston Holdings, Inc. (NYSE:LW) shares dipped 18.6% to $63.50 in pre-market trading as the company posted downbeat quarterly results and lowered FY25 outlook.
- Nvni Group Limited (NASDAQ:NVNI) fell 18.5% to $0.5213 in today's pre-market trading after jumping 52% on Wednesday.
- Micron Technology, Inc. (NASDAQ:MU) dipped 15.6% to $87.60 in pre-market trading. Micron posted better-than-expected earnings for its first quarter, while sales missed expectations. The company said it sees second-quarter revenue of $7.9 billion, plus or minus $200 million, versus estimates of $9 billion. The company expects second-quarter adjusted earnings of $1.43 per share, plus or minus 10 cents per share, versus estimates of $1.92 per share.
- Virax Biolabs Group Limited (NASDAQ:VRAX) fell 15.6% to $2.00 in pre-market trading after surging 39% on Wednesday.
- Quantum BioPharma Ltd. (NASDAQ:QNTM) shares fell 14.5% to $2.95 in pre-market trading after dipping 18% on Wednesday.
- Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 14.3% to $0.3008 in pre-market trading following a 30% plunge on Wednesday.
- Design Therapeutics, Inc. (NASDAQ:DSGN) fell 14.2% to $5.10 in pre-market trading after declining 5% on Wednesday.
- Snow Lake Resources Ltd.(納斯達克:LITM)在美股盤前交易中股價暴跌40.5%,達$0.4847,此前週三跳漲348%。
- Aethlon Medical, Inc.(納斯達克:AEMD)在美股盤前交易中下跌了36.4%,至0.42美元,此前週三上漲超過80%。
- Abacus Life, Inc.(納斯達克:ABL)在美股盤前交易中下跌了20.5%,至6.00美元。
- Lamb Weston Holdings, Inc.(紐交所:LW)在美股盤前交易中下跌了18.6%,至63.50美元,因爲該公司發佈了低於預期的季度業績,並下調了2025財年的展望。
- Nvni Group Limited(納斯達克:NVNI)在今天的美股盤前交易中下跌了18.5%,至0.5213美元,此前週三上漲了52%。
- 美光科技(納斯達克:MU)在美股盤前交易中下跌了15.6%,至87.60美元。美光在第一季度的盈利好於預期,但銷售未達到預期。該公司表示,預計第二季度營業收入爲79億,上下浮動20000萬,而預估爲90億。該公司預計第二季度調整後每股盈利爲1.43美元,上下浮動10美分,而預估爲每股1.92美元。
- Virax Biolabs Group Limited(納斯達克:VRAX)在美股盤前交易中下跌了15.6%,至2.00美元,此前週三上漲了39%。
- Quantum BioPharma Ltd.(納斯達克:QNTM)在美股盤前交易中下跌了14.5%,至2.95美元,此前週三下跌了18%。
- Petros Pharmaceuticals, Inc.(納斯達克:PTPI)在美股盤前交易中下跌了14.3%,至0.3008美元,此前週三下跌了30%。
- Design Therapeutics, Inc. (納斯達克:DSGN) 在美股盤前交易中下跌14.2%,至5.10美元,此前在週三下跌了5%。
Now Read This:
現在閱讀這個:
- Top 3 Tech And Telecom Stocks That May Crash This Month
- 本月可能暴跌的三大科技與電信股票
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。